We are live on ! Find out more
AEMD icon

Aethlon Medical

7 hedge funds and large institutions have $2.3M invested in Aethlon Medical in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 67 (+1)

16% more capital invested

Capital invested by funds: $1.98M → $2.3M (+$317K)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q2 2016 in Review

7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2016, worth a combined $2.3M — up 16% from $1.98M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new AEMD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $64.7K. The largest seller was Thompson Davis & Co, cutting an estimated $16K.

  • 7 institutional investors held Aethlon Medical (AEMD) as of Q2 2016, up from 6 in Q1 2016.
  • Funds reported $2.3M of Aethlon Medical stock for Q2 2016, up 16% quarter-over-quarter.
  • 1 fund opened new Aethlon Medical positions in Q2 2016 and 0 closed out, a net change of +1 holder.
  • The largest Aethlon Medical buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $64.7K added.
  • The largest Aethlon Medical seller in Q2 2016 was Thompson Davis & Co, an estimated $16K sold.

Based on aggregated 13F filings for Q2 2016.